By constructing compact, accessible, and reasonably priced dialysis facilities with two to three beds in rural and semi-urban regions, Shashank Modhia’s Renal Project seeks to transform dialysis care in India. Due to exorbitant expenses and a lack of nearby facilities, millions of Indians with renal failure find it difficult to receive dialysis, which the firm fills in a key healthcare gap. The Renal Project is a network of local dialysis facilities that provide patients, particularly those in rural and semi-urban regions, with accessible and reasonably priced dialysis therapy. The Renal Project establishes 2-3 bed micro-centers in rural and small towns, in contrast to conventional dialysis facilities with 10–20 beds.

Company Name: The Renal Project

Founder: Shashank Modhia

Product: Home Dialysis Treatment

Highlights

• In order to make dialysis more accessible and reasonably priced, particularly in rural and semi-urban regions, the Renal Project focuses on establishing modest, two to three bed dialysis facilities.
• Micro-dialysis facilities are a novel idea that might grow rapidly without requiring significant infrastructure expenditure.
• The startup made a compelling argument for investor-backed growth in the healthcare sector by proving that companies in this sector can be both profitable and have an effect.
• Given the stringent compliance standards of the healthcare industry, sharks expressed concerns around scalability, operational efficiency, and regulatory issues.
• The business model comprises reasonably priced medical care, expands rapidly and requires less setup. Reaching underprivileged communities by collaborating with neighborhood clinics, small hospitals, and healthcare providers, rapid scaling is made possible by the asset-light model.
• The valuation was lowered to ₹16.67 crore when Aman Gupta and Namita Thapar contributed ₹1 crore for 6% equity. The updated offer was accepted by the founder.
• The Healthcare Experience of Namita Thapar She can assist in expanding operations and collaborations as a pharmaceutical leader.
• Business Growth Insights from Aman Gupta: Assistance with branding and expansion plans.
• The Renal Project hopes to transform dialysis care with this money, giving millions of Indians greater access to life-saving care.

Pitch Details

Ask: ₹1 Crore for 3% Equity

Deal: After negotiations, Aman and Namita secured a deal for ₹1 Crores for 6% Equity.

Investors: The investment came from Aman Gupta and Namita Thapar.

Conclusion

A significant healthcare issue—the dearth of easily accessible and reasonably priced dialysis facilities, particularly in rural and semi-urban areas—was brought to light in The Renal Project’s pitch. The Sharks were fascinated by the startup’s micro-dialysis center approach because it was affordable, scalable, and had the potential to have a big social impact. However, during the conversation, issues of competition, operational effectiveness, and scalability were brought up.

Not with standing these reservations, Aman Gupta and Namita Thapar saw the company’s great potential and, confident in its sustainability and long-term effects, provided ₹1 crore for 6% shares. The agreement gives The Renal Project the funding and strategic guidance it needs to broaden its audience, increase access to healthcare, and boost operational effectiveness.
All things considered, the pitch demonstrated a mission-driven business strategy that holds significant potential in India’s healthcare industry, demonstrating that social impact and corporate expansion can coexist.

Significant findings

• Addressing a Critical Healthcare Need
• Scalable and Impact-Driven Model
• Challenges in Expansion
• Investment from Strategic Sharks
• Balancing Profit and Social Impact